Michael Peter Short
Keine laufenden Positionen mehr
Profil
Mr. Michael P.
Short is Vice President-Business Strategy & Development at Embera NeuroTherapeutics, Inc. He is on the Board of Directors at 4C Consulting Ltd.
Mr. Short was previously employed as General Manager by PathoGenesis Corp, a Principal by Baxter International, Inc., Chief Executive Officer by GlycoForm Ltd., Chief Executive Officer by RioTech Pharmaceuticals Ltd., Chief Executive Officer by Iridian Technologies, Inc., and President, VP-Business Strategy & Development by BaroFold, Inc.
He received his MBA from the University of Aston.
Ehemalige bekannte Positionen von Michael Peter Short
| Unternehmen | Position | Ende |
|---|---|---|
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Corporate Officer/Principal | 01.01.2000 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.1996 |
4C Consulting Ltd.
 4C Consulting Ltd. Miscellaneous Commercial ServicesCommercial Services 4C Consulting Ltd. provides financial consulting services. The company was founded on August 3, 2015 and is headquartered in Elstree, the United Kingdom. | Direktor/Vorstandsmitglied | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Vorstandsvorsitzender | - |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Präsident | - |
Ausbildung von Michael Peter Short
| University of Aston | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
Iridian Technologies, Inc.
 Iridian Technologies, Inc. Information Technology ServicesTechnology Services Iridian Technologies, Inc. develops and commercializes authentication recognition software solutions. Its recognition enables both physical access security and information network security. The firm also offers enabling technology for large-scale identification applications, physical facilities, information networks, and electronic transactions. The company was founded in 1986 and is headquartered in Moorestown, NJ. | Technology Services |
RioTech Pharmaceuticals Ltd.
 RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Health Technology |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Health Technology |
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
4C Consulting Ltd.
4C Consulting Ltd. Miscellaneous Commercial ServicesCommercial Services 4C Consulting Ltd. provides financial consulting services. The company was founded on August 3, 2015 and is headquartered in Elstree, the United Kingdom. | Commercial Services |
